Allurion Technologies Inc. (ALUR)
OTCMKTS · Delayed Price · Currency is USD
0.3600
+0.0998 (38.36%)
At close: Mar 12, 2026

Allurion Technologies Company Description

Allurion Technologies Inc. focuses on ending obesity with a weight loss platform to treat people who are overweight.

Its platform offers the Allurion Program, a swallowable and procedure-less intragastric balloon for weight loss, as well as provides access to artificial intelligence-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion Virtual Care Suite.

The company operates in Spain, France, Turkey, and internationally. Allurion Technologies Inc. is headquartered in Natick, Massachusetts.

Allurion Technologies Inc.
Allurion Technologies logo
CountryUnited States
IndustryMedical Devices
SectorHealthcare
Employees137
CEOShantanu Gaur

Contact Details

Address:
11 Huron Drive
Natick, Massachusetts 01760
United States
Phone508 647 4000
Websiteallurion.com

Stock Details

Ticker SymbolALUR
ExchangeOTCMKTS
Stock TypeCommon Stock
Fiscal YearJanuary - December
Reporting CurrencyUSD
ISIN NumberUS02008G1022
SIC Code3841

Key Executives

NamePosition
Dr. Shantanu K. Gaur M.D.Co-Founder, Chief Executive Officer, President, Principal Financial and Accounting Officer and Director
Ojas A. BuchChief Operating Officer
Brendan Michael Gibbons J.D.Chief Legal Officer and Corporate Secretary
Dr. Samuel G. LevyCo-Founder
Dr. Ram Chuttani M.D.MD, Chief Medical Officer and Founding Partner
Alexandra van der StapVice President of Global Marketing
Laurent LaffineurVice President of International Sales and Marketing
Matt WrightVice President of People